Literature DB >> 7519637

Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis.

C M Eischen1, C J Dick, P J Leibson.   

Abstract

Selective cell death plays a critical role in the development of the immune repertoire and in the elimination of target cells expressing foreign Ags. The apoptosis induced by ligation of the Fas Ag, a member of the TNFR/nerve growth factor receptor superfamily, contributes to both of these modes of cell loss. However, in spite of the molecular cloning of the Fas Ag and the identification of a specific cytoplasmic domain required for its function, it remains unclear as to which Fas-induced second messengers mediate the development of programmed cell death. We, therefore, evaluated Fas-initiated signal transduction in susceptible cell types. We determined that Fas ligation induces the rapid tyrosine phosphorylation of multiple cellular proteins. These phosphorylation events occur within 1 min and decline toward baseline by 30 min. In addition, Fas ligation increases the in vitro protein kinase activity of the tyrosine phosphorylated proteins. Pharmacologic inhibitors of protein tyrosine kinases block, in a concentration-dependent manner, Fas-induced DNA fragmentation and prolong cell survival. These results suggest that protein tyrosine kinase activation is an early and obligatory signal in Fas-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519637

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD).

Authors:  Y Okada; E Maeno; T Shimizu; K Dezaki; J Wang; S Morishima
Journal:  J Physiol       Date:  2001-04-01       Impact factor: 5.182

2.  Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases.

Authors:  E Gulbins; I Szabo; K Baltzer; F Lang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 3.  Looking beneath the surface: the cell death pathway of Fas/APO-1 (CD95).

Authors:  B Z Stanger
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

4.  Upregulated expression of Fas antigen on cultured human keratinocytes with induction of apoptosis by cisplatin.

Authors:  Y Matsumoto; A Hayakawa; Y Tamada; H Mori; M Ohashi
Journal:  Arch Dermatol Res       Date:  1996-05       Impact factor: 3.017

5.  Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes.

Authors:  I Szabò; A Lepple-Wienhues; K N Kaba; M Zoratti; E Gulbins; F Lang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Calmodulin mediates Fas-induced FADD-independent survival signaling in pancreatic cancer cells via activation of Src-extracellular signal-regulated kinase (ERK).

Authors:  Kaiyu Yuan; Gu Jing; Jianfeng Chen; Hui Liu; Kui Zhang; Yuebin Li; Hui Wu; Jay M McDonald; Yabing Chen
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

7.  FAS associated phosphatase (FAP-1) blocks apoptosis of astrocytomas through dephosphorylation of FAS.

Authors:  Erik D Foehr; Gustavo Lorente; Valerie Vincent; Karoly Nikolich; Roman Urfer
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

Review 8.  Kinase cascades regulating entry into apoptosis.

Authors:  P Anderson
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

9.  Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.

Authors:  W C Liles; P A Kiener; J A Ledbetter; A Aruffo; S J Klebanoff
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

10.  Fas (CD95) expression and death-mediating function are induced by CD4 cross-linking on CD4+ T cells.

Authors:  J Desbarats; J H Freed; P A Campbell; M K Newell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.